24.02.2016 Fresenius SE & Co. KGaA  DE0005785604

DGAP-Adhoc: Fresenius SE & Co. KGaA: Outstanding 2015 financial results - 25% dividend increase proposed - Positive Group guidance for 2016 - New stretch targets for 2019


 
Fresenius SE & Co. KGaA / Key word(s): Forecast/Final Results 24.02.2016 07:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Group sales increased by 19% (9% in constant currency) to EUR27,626 million (2014: EUR23,231 million). Organic sales growth was 6%. Acquisitions contributed 4% and divestitures reduced sales by 1%. Currency translation had a positive effect of 10%. Group EBIT* increased by 25% (13% in constant currency) to EUR3,958 million (2014: EUR3,158 million). The EBIT margin* increased to 14.3% (2014: 13.6%). Group net income** before special items increased by 31% (21% in constant currency) to EUR1,423 million (2014: EUR1,086 million). Earnings per share** before special items increased by 30% (20% in constant currency) to EUR2.61 (2014: EUR2.01). Group net income** including special items increased by 27% (17% in constant currency) to EUR1,358 million (2014: EUR1,067 million). Earnings per share** including special items increased by 27% (16% in constant currency) to EUR2.50 (2014: EUR 1.97). Based on the strong financial results, the Management Board will propose to the Supervisory Board a dividend increase of 25% to EUR0.55 per share (2014: EUR0.44). For 2016, Fresenius projects sales growth of 6% to 8% in constant currency. Net income*** is expected to grow by 8% to 12% in constant currency. For 2019, Group sales are expected to reach EUR36 billion to EUR40 billion****. Group net income** is expected to increase to EUR2.0 billion to EUR2.25 billion****. * Before special items ** Net income attributable to shareholders of Fresenius SE & Co. KGaA *** Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015 before special items **** At comparable exchange rates; including small and mid-size acquisitions (Financial statements according to U.S. GAAP) Fresenius SE & Co. KGaA, represented by Fresenius Management SE, Board of Management Bad Homburg v.d.H., February 24, 2016 End of note 24.02.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Germany Phone: +49 (0)6172 608-2485 Fax: +49 (0)6172 608-2488 E-mail: [email protected] Internet: www.fresenius.com ISIN: DE0005785604 WKN: 578560 Indices: DAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 33.530,00 35.409,00 37.250,00 36.277,00 37.520,00 40.840,00 22.299,00
EBITDA1,2 6.267,00 6.032,00 7.083,00 7.132,00 6.854,00 6.808,00 3.422,00
EBITDA-Marge3 18,69 17,04 19,01 19,66 18,27 16,67
EBIT1,4 4.589,00 5.251,00 4.631,00 4.385,00 4.158,00 3.321,00 1.143,00
EBIT-Marge5 13,69 14,83 12,43 12,09 11,08 8,13 5,13
Jahresüberschuss1 1.816,00 1.871,00 1.915,00 2.823,00 2.819,00 2.117,00 -594,00
Netto-Marge6 5,42 5,28 5,14 7,78 7,51 5,18 -2,66
Cashflow1,7 3.937,00 3.742,00 4.263,00 6.549,00 5.078,00 4.198,00 4.456,00
Ergebnis je Aktie8 3,25 3,37 3,44 3,06 3,26 2,44 -1,05
Dividende8 0,75 0,80 0,84 0,88 0,92 0,92 0,62
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Fresenius
WKN Kurs in € Einschätzung Börsenwert in Mio. €
578560 27,630 Halten 15.562,25
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,28 16,63 0,80 11,12
KBV KCV KUV EV/EBITDA
0,82 3,49 0,70 8,42
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,92 0,00 0,00 17.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 31.07.2024 06.11.2024 20.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,88% 1,54% -1,57% 0,77%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Fresenius SE & Co. KGaA  ISIN: DE0005785604 können Sie bei EQS abrufen


Medtech , 578560 , FRE , XETR:FRE